1. Xie Xinran*, Zhang Lei, Lin Yan, Liu Xin, Han Xxuyang, Li Ping*. Liangxue Jiedu formula improves imiquimod-induced psoriasiform dermatitis with circadian desynchrony by regulating Th17 cell differentiation based on network pharmacological analysis.Journal of Ethnopharmacology.2023.317.116807.SCI |
2. 解欣然,张蕾,李雪,林燕,刘卫红,韩旭阳,李萍*.基于LC-MS分析凉血解毒利湿方对咪喹莫特诱导ApoE-/-小鼠的血清脂质组学的影响.时珍国医国药.2023.34(2).260-264.核心期刊 |
3. Sun Liyun, Guo Xinwei, Qin Yeping, Li Ping, Yu Chunxia, Gao Xuesong, Xie Xinran*,Xu Xuying*.Serum Intestinal Metabolites are Raised in Patients with Psoriasis and Metabolic Syndrome..Clinical Cosmetic and Investigational Dermatology.2022.15.879-886.SCI |
4. Xie Xinran*,Zhang Lei,Li Xue,Liu Weihong,Wang Ping,Lin Yan,Han Xuyang and Li Ping*.Liangxue Jiedu Formula Improves Psoriasis and Dyslipidemia Comorbidity via PI3K/Akt/mTOR Pathway.Frontiers in Pharmacology.2021.12.591608.SCI |
5. 张蕾,李萍,刘卫红,林燕,解欣然*.清血消脂方对小鼠银屑病合并脂代谢紊乱模型的干预作用.医药导报.2021.40(12).1633-1639.核心期刊 |
6. 解欣然,张蕾,刘欣,林燕,李萍*.丹皮酚通过STAT3通路抑制IL-17A诱导的角质形成细胞活性和细胞因子分泌.中国病理生理杂志.2020.36(10).1854-1859.核心期刊 |
7. 解欣然.昼夜节律钟和银屑病的研究进展.中国皮肤性病学杂志.2020.34(9).1083-1086.核心期刊 |
8. 李雪,李萍,王燕,解欣然*.鸡血藤在银屑病中的应用及现代研究进展.中华中医药学刊.2018.36(2).360-364.核心期刊 |
9. Xie Xinran,Zhang Lei,Lin Yan,Wang Yan,Liu Weihong,Li Xue,Li Ping*.Imiquimod induced ApoE-deficient mice might be a composite animal model for the study of psoriasis and dyslipideamia comorbidity.Journal of Dermatological Science.2017.88.20-28.SCI |
10. 解欣然,张蕾,刘欣,林燕,张璐,李萍*.紫草素对IL-17诱导角质形成细胞增殖及趋化因子表达的影响.中国中药杂志.2015.40(5).71-74.核心期刊 |
11. 解欣然,刘欣,王燕,张璐,李萍*.凉血解毒方及拆方对活化T淋巴细胞致角质形成细胞增殖及分泌细胞因子的影响.中国中药杂志.2013.38(22).3953-3956.核心期刊 |